# Hypoalbuminaemia in haemodialysis patients at Parirenyatwa group of hospitals and Chitungwiza central hospital

**Authors:** Pasipanodya Ian Machingura, Needmore Muchadura Mahiya, Vasco Chikwasha

PMC · DOI: 10.11604/pamj.2015.21.79.4171 · The Pan African Medical Journal · 2015-06-01

## TL;DR

This study found that 76.7% of hemodialysis patients had low albumin levels, which is linked to higher risks of illness and death.

## Contribution

The study reports the prevalence of hypoalbuminaemia in hemodialysis patients in specific Zimbabwean hospitals.

## Key findings

- The mean serum albumin concentration was 33.6 g/L with a standard deviation of 6.1 g/L.
- The prevalence of hypoalbuminaemia was 76.7% among the studied hemodialysis patients.
- There was no statistically significant difference in albumin levels between male and female patients.

## Abstract

Haemodialysis is one of the widely used methods in end stage renal disease. However it has a negative impact on the quality of life of the renal patients. Hypoalbuminaemia occur in haemodialysis patients and it correlates strongly with mortality and morbidity. We sought out to determine the prevalence of hypoalbuminaemia among haemodialysis patients at Parirenyatwa group of hospitals and Chitungwiza central hospital.

A questionnaire was administered on haemodialysis patients at Parirenyatwa Group of Hospitals and Chitungwiza Central Hospital who consented to participate in the study. Pre dialysis serum samples collected from the patients were used for albumin analysis. The serum from the patients was analysed for serum albumin levels using the Mindray BS120 chemistry analyser using the bromocresol green method.

A total of 60 patients were recruited from the two hospitals. The Mean albumin concentration for the entire group was 33.6g/L SD (6.1 g/L). The mean albumin in males was 33.6 g/L, SD (5.9) and in female 33.6, SD (6.6 g/L) and this was not statistically significantly different (p = 0.988). The prevalence of hypoalbuminaemia was 76.7%.

Hypoalbuminaemia in 76.7% of haemodialysis patients studied is a cause of concern thus monitoring of haemodialysis patients albumin is necessary since its decreased levels has been associated with increased morbidity and mortality.

## Linked entities

- **Diseases:** end stage renal disease (MONDO:0004375)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** malnutrition (MESH:D044342), inflammatory (MESH:D007249), hypoalbuminemia (MESH:D034141), End stage renal disease (MESH:D007676), chronic kidney disease (MESH:D051436), protein energy wasting (MESH:D011502)
- **Chemicals:** bromocresol green (MESH:D001961)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4594974/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC4594974/full.md

---
Source: https://tomesphere.com/paper/PMC4594974